Government in court over Abingdon Health Covid contracts scandal

“Once again, it’s taken legal action to shine a light on dodgy procurement, wasted millions and preferential treatment for the politically-connected.”

Rapid antigen tests

The Good Law Project’s legal challenge against the government’s award of multi-million-pound contracts to Abingdon Health is to reach its judicial review hearing in the High Court on May 3.

Throughout the Covid-19 pandemic, allegations of Tory MPs helping associates gain lucrative Covid contacts were abundant. Matt Hancock, the former health secretary, was even found to have acted unlawfully by failing to publish details of Covid contacts. 

One high-profile case involving accusations of Tory cronyism and dodgy contract practices during the pandemic, involves Abingdon Health, a British manufacturer of rapid lateral flow tests.

The fortunes of Abingdon Health quickly shifted from ‘teetering on the brink’ with losses of £1.5m in 2019, to floating on the AIM small firms stock market in 2020, raising £22m from investors. 

Multiple contracts awarded to Abingdon Health

The first contract awarded to Abingdon was made in April 2020 and was a research grant to develop lateral flow tests worth £2.5m. In June 2020, a second grant was awarded for £10m to supply components for 10m lateral flow test kits. A third contract was awarded to the firm in August 2020, for a potential £75m to supply 1 million lateral flow tests for professional use and the option to order a further 9 million home-use tests.

According to the Good Law Project, all contracts were awarded without advertisement or competition, and without any lawful decision-making process, a prevalent concern of the government’s apparent bias in the granting of contracts to longstanding associates.  

A report in the British Medical Journal (BMJ) on the case, notes how after arguments presented on paper, it was ruled that the Good Law Project could mount a High Court challenge on the ground that the award breached the government’s equal treatment obligations.

However, after hearing both sides, Mr Justice Waksman considerably widened the scope of the challenge. The decision meant that when the case reached court the Good Law Project could argue that there was apparent bias in the award of the contracts, that the government awarded the contracts to Abingdon Health unlawfully by giving it preferential treatment because it was a British company, that the decision to award the contracts breached the government’s obligations of equal treatment, transparency, and proportionality, that the contract awards led to unlawful state aid, and that the government acted irrationally when awarding the contracts to Abingdon Health.

In November 2020, the Good Law Project, which aims to achieve change through the law, launched the case against the government’s decision to award contracts to Abingdon Health.

‘Ever changing excuses’ from government

Since launching the case, the Good Law Project says it has heard “ever-changing excuses from government about their conduct, revealed persistent use of private communications channels for important government business and uncovered a secret VIP process for testing contracts, as we did for PPE contracts.”

Despite being awarded these huge sums of money, the government has seemed to ignore concerns that Covid-19 tests were not fit for purpose.

Gemma Abbott, legal director at the Good Law Project commented: “The government has struggled to get their story straight on the Abingdon Health shambles. Once again, it’s taken legal action to shine a light on dodgy procurement, wasted millions and preferential treatment for the politically-connected. The government has fought tooth and nail to prevent this coming to light, at every stage. Accountability shouldn’t be this difficult.”

The legal challenge, which rests on the grounds of the government’s apparent failure to conduct any lawful or sufficient inquiry or evaluation of the accuracy of the rapid antibody tests, and the award of the contracts was seemingly made without any advertisement or competition between bidders, is being crowdfunded. It has currently raised almost £130k or its £150k target.

Gabrielle Pickard-Whitehead is a contributing editor to Left Foot Forward

Comments are closed.